Member Info for DeBull

I believe Adam is too busy with getting VAL sorted to bother with PYC. Slater is / was also in VAL bif time, i dont think he has mentioned PYC in years?

Looking back thru history, yes there is a Gary Marshall who works for a US biotech , There is a GM who is listed as a TR1 holder. However, GM is quite a common name and there is no evidence i can find of the GM in the US coy as the TR1 holder here.

Then there is Ben Ryden who is a TR1 holder, have they increased their holding? The WRAP was for only £25k so only a tiny amount. It is possible one investor/trader took it all, await the bounce and dump for 50%+ ?

The significant shareholders list is updated next in August i think?, so we may find out then? However, after the other days raise and subsequent issue in millions of shares, everyone has been diluted so these 3% + holders may not appear on the list as their dilution will be under 3% now? Unless someone pops out and states publicly that they own 3% or more then we will probably never know?

I agree with King and Stephen, the complete lack of BOD buying is a worry, especially in the last raise. I think at the last IM, that everyone question this and see if we get a reply?

Thank you Stephen for the posting of your reply. At least you have one, my email must have been too strongly worded to warrant a reply.

Thank you Laura.

As for Telegram, all i have seen is there was slating of the raise yesterday, and a poster quoting Solomon.

Laura, they are not going to get 6m from VAL201, its 6% or up to 6m i believe. If that ever come to fruition we have to wait and see. That deal is so hidden in the long grass, itll take many more harvests for it to show.

I have sent a strongly worded email to PS, has anyone else? Anyone had a reply?

They mentioned Biostatistics info by end of financial year, that is now overdue.

Thank you Ant and King and others for their measured responses today, i for one hope that Ant's email ruffles some feathers back in Bee House, but very much doubt it.

Many have been negative on Share4 & ILS but as i said this morning, they have unfortunately called this down the middle.

Was also interested in Porkys post to. I remember you saying that you (Porky) thought PS was a "honest broker" is that still the case?

I still have not had a reply to a email i sent to PS some weeks ago, so very much doubt if i send one now, it will be either read or replied to.

Probably because he knew that he could not get it away unless it was this low.

Why would i be commenting if i did not own shares? That seems stupid. The way things are going, the shares are not worth the paper they are on.

Yes, over 1.5m,

I believe in a few of the past raises, the BOD have taken some, this time, nothing, that shows real confidence NOT!

In 1 foul swoop, and foul being the key word here, they have alienated and shafted LTH's . If i were PS i would keep away from the phone and email for the next few weeks.

Only glimmer of light in this RNS of shareholder value destruction is:

Implementation of the personalised dosing tool on the DoseMeRx Platform, enabling it to be available to clinicians across the US and deliver on a study in partnership with DoseMeRx to further develop the tools H-CSF functionality.

Also, got into bed with Winterfloods.............abandon ship?

The Company values its retail shareholder base................yeah right, sure you do.

Existing shareholders can contact their broker or wealth manager to participate in the WRAP Retail Offer............................ at this point, there is nearly no wealth left............

Awaiting ILS and Share4 to say "i told you so" & they were right.

At this rate there will be no shareholders left to participate in the £25k.

PATHETIC.

Https://www.londonstockexchange.com/news-article/PYC/completion-of-placing-wrap-retail-offer-launch/16549509

https://www.londonstockexchange.com/news-article/PYC/wrap-retail-offer-for-up-to-ps25-000/16549507

Looks like they missed their own deadline?

Anyone else think it strange that they announce the appointment of Dr Venkata https://www.investegate.co.uk/announcement/rns/physiomics--pyc/senior-management-announcement-/7792394 but as yet not announced the appointment of Dr Michael?

Or is it because Dr Venkata was a "Head" and Dr Michael is "Principal" ?

Looks like Docetaxel has moved from "in review" to "development" ??

https://doseme-rx.com/why-dosemerx/drug-packages

He has been about, "Allergy Therapeutics, TEVA, GSK, and AstraZeneca), and CRO companies (hVIVO, Veramed, Certara) as a statistician supporting the design of clinical trials from Phase I (e.g., bioequivalence, dose-escalation, and dose-proportionality) to Phase II, Phase III, and Phase IV (post-approval)."

I see Certara are mentioned along with GSK and AZ. Also has experience with FDA. He has authored / co Authored numerous publications, but none for nearly 2 years.

Hopist i see you have again mentioned a "buy order" being worked. I do not mean to be disrespectful, but you quoted that some weeks ago, and at the time i doubted this was happening. So it proved, so i doubt there are any buy orders in the back ground at the moment.

Some one mentioned that there were large buys, yes there were, but also lots of sells, hence why the price dropped the other day, only to recover later in the day.

Yesterday, the sells continued, and the price could not recover. As the price is 1.10 its not hard to see a "large buy" as only a few thousand £ purchase will get you a few hundred thousand shares.

What i do not get is, with all these shares being sold, some are finding it easier to buy than others. Others can only buy a small amount. Why are the MM not making a market? There should be loads of excess shares sloshing about with these sells?